Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.4% |
| 2 | Technology | 3.32% |
| 3 | Consumer Discretionary | 2.87% |
| 4 | Financials | 2.84% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8801
Everspin Technologies
MRAM
$341M
| $102K | ﹤0.01% |
14,649
-2,076
| -12% | -$10.2K |
|
|
MRCC
8802
DELISTED
Monroe Capital Corp
MRCC
| $102K | ﹤0.01% |
14,654
-10,959
| -43% | -$80.7K |
|
8803
CALL
Televisa
TV
$1.48B
| $102K | ﹤0.01% |
+19,400
| New | +$107K |
|
8804
CALL
Vermilion Energy
VET
$1.82B
| $102K | ﹤0.01% |
22,800
-22,300
| -49% | -$105K |
|
8805
CALL
Select Water Solutions
WTTR
$2.3B
| $102K | ﹤0.01% |
20,900
-2,400
| -10% | -$11K |
|
8806
PUT
Ardelyx
ARDX
$1.22B
| $101K | ﹤0.01% |
14,600
-8,600
| -37% | -$59.8K |
|
8807
Asure Software
ASUR
$232M
| $101K | ﹤0.01% |
+15,687
| New | +$97.9K |
|
|
CRESY
8808
Cresud
CRESY
$795M
| $101K | ﹤0.01% |
35,567
-5,147
| -13% | -$16.4K |
|
8809
Gilat Satellite Networks
GILT
$834M
| $101K | ﹤0.01% |
15,879
-831
| -5% | -$6.39K |
|
8810
CALL
Global Partners
GLP
$1.68B
| $101K | ﹤0.01% |
+10,300
| New | +$106K |
|
8811
Team
TISI
$79.5M
| $101K | ﹤0.01% |
1,826
-180
| -9% | -$9.95K |
|
|
AVID
8812
CALL
DELISTED
Avid Technology Inc
AVID
| $101K | ﹤0.01% |
+13,900
| New | +$91.7K |
|
|
FPRX
8813
CALL
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $101K | ﹤0.01% |
16,500
+5,200
| +46% | +$21.4K |
|
8814
Ceragon Networks
CRNT
$197M
| $100K | ﹤0.01% |
46,374
-6,202
| -12% | -$13K |
|
8815
Lineage Cell Therapeutics
LCTX
$269M
| $100K | ﹤0.01% |
114,230
+51,293
| +81% | +$45.1K |
|
8816
PUT
Pitney Bowes
PBI
$2.4B
| $100K | ﹤0.01% |
38,300
-9,100
| -19% | -$22.7K |
|
|
RVLP
8817
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $100K | ﹤0.01% |
14,880
-44,943
| -75% | -$220K |
|
|
IO
8818
DELISTED
ION Geophysical Corporation
IO
| $100K | ﹤0.01% |
+42,818
| New | +$93.5K |
|
8819
PUT
Fennec Pharmaceuticals
FENC
$332M
| $99K | ﹤0.01% |
+11,800
| New | +$87.8K |
|
8820
PUT
Geron
GERN
$828M
| $99K | ﹤0.01% |
45,400
+11,700
| +35% | +$17.5K |
|
8821
CALL
iHeartMedia
IHRT
$543M
| $99K | ﹤0.01% |
+11,800
| New | +$91.9K |
|
8822
Marker Therapeutics
MRKR
$18.8M
| $99K | ﹤0.01% |
4,768
-1,612
| -25% | -$35.3K |
|
8823
CALL
Newmark Group
NMRK
$2.66B
| $99K | ﹤0.01% |
+20,300
| New | +$85.3K |
|
8824
Quantum Corp
QMCO
$419M
| $99K | ﹤0.01% |
1,279
-486
| -28% | -$38.5K |
|
|
GRCE
8825
Grace Therapeutics
GRCE
$33.8M
| $99K | ﹤0.01% |
4,380
+2,876
| +191% | +$83.9K |
|
Similar funds
Citadel Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Citadel Advisors held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in Becton Dickinson worth $266M.
- Citadel Advisors's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Citadel Advisors added most to Amazon in Q2 2020, an estimated $861M increase.
- Citadel Advisors's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Citadel Advisors fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Citadel Advisors's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Citadel Advisors opened 1,506 new positions and closed 1,324 in Q2 2020.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.